Business Context and Reporting Period
Company: The Hain Celestial Group, Inc. (HAIN)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended March 31, 2025
Business Overview: A global health and wellness company operating in two segments: North America and International. The company is executing the "Hain Reimagined" transformation program to optimize its portfolio, focusing on Better-For-You (BFY) platforms (Snacks, Baby & Kids, Beverages, Meal Preparation) and exploring strategic alternatives for its Personal Care business.
Key Financial Metrics
| Metric | Three Months Ended March 31, 2025 |
Nine Months Ended March 31, 2025 |
|---|---|---|
| Net Sales | $390.4 million | $1,196.4 million |
| Gross Profit | $84.7 million (21.7% margin) | $259.7 million (21.7% margin) |
| Operating Loss | $(121.1) million | $(209.9) million |
| Net Loss | $(134.6) million | $(258.2) million |
| Diluted EPS | $(1.49) | $(2.87) |
| Adjusted EBITDA | $33.6 million | $93.9 million |
| Cash and Equivalents | $44.4 million | $44.4 million (Balance Sheet) |
| Total Debt | $709.0 million | $709.0 million (Balance Sheet) |
| Free Cash Flow | N/A | $5.7 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 11.0% ($48.0 million) for the quarter and 9.2% ($121.1 million) for the nine months compared to the prior year. Organic net sales declined 5.3% (quarter) and 5.2% (nine months), driven by volume/mix decreases and promotional pricing.
- Significant Impairments: The company recorded a non-cash goodwill impairment charge of $110.3 million for the quarter ($201.5 million for the nine months) related to U.S. and Canada reporting units. Additionally, $24.0 million in long-lived asset and intangible impairments were recorded for the quarter, primarily related to the Personal Care business held for sale.
- Segment Performance:
- North America: Sales down 17.0% (quarter) and 14.2% (nine months). Adjusted EBITDA down 37.9% (quarter) and 29.2% (nine months) due to lower volume and unfavorable pricing.
- International: Sales down 1.4% (quarter) and 1.5% (nine months). Adjusted EBITDA down 9.7% (quarter) and 4.3% (nine months).
- Divestitures: Completed the sale of the ParmCrisps business in August 2024 for $12.0 million, recognizing a pretax loss of $3.9 million.
Guidance, Outlook, and Risks
- Hain Reimagined Program: The multi-year transformation program is expected to generate annualized pretax savings of $130 million - $150 million. Cumulative pretax charges are expected to be $115 million - $125 million, including potential inventory write-downs of ~$25 million.
- Personal Care Strategy: The company is exploring strategic alternatives for its Personal Care business, which has been classified as "held for sale."
- Debt Covenant Amendment: On May 5, 2025, the company entered into a Third Amendment to its Credit Agreement. This reduced the Revolver size from $800 million to $700 million and adjusted leverage ratios. The company remains in compliance with all covenants.
- Legal Contingencies:
- Baby Food Litigation: Ongoing class actions and multidistrict litigation (MDL) regarding heavy metals in Earth's Best products. A trial in a California state court is set for July 2025. The Supreme Court granted a petition for certiorari regarding the Palmquist case.
- SEC Investigation: Concluded in February 2025 with no enforcement action recommended.
- Market Risks: Risks include supply chain disruptions, input cost inflation, tariffs, and potential further goodwill impairments if cash flow projections are not met.
Investor Verification Checklist
- Impairment Sustainability: Verify if the $201.5 million goodwill impairment is a one-time event or indicative of ongoing valuation pressure on North America assets.
- Personal Care Exit: Monitor progress on the sale of the Personal Care business and the associated write-downs ($23.1 million recorded to date).
- Liquidity Position: Assess the impact of the reduced credit facility ($700 million cap) and the current debt load ($709 million) against operating cash flows ($24.8 million for nine months).
- Legal Exposure: Track the outcome of the pending baby food litigation trials and the Supreme Court review, as adverse rulings could result in significant damages.
- Organic Growth: Evaluate the company's ability to reverse the 5.2% organic sales decline through the "Hain Reimagined" cost-cutting and portfolio optimization initiatives.